Latest News about CYAD
Recent news which mentions CYAD
Earnings Scheduled For March 24, 2022
March 24, 2022
From Benzinga
From Benzinga
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 04, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 07, 2021
From Benzinga
58 Biggest Movers From Friday
December 06, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 03, 2021
From Benzinga
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
December 03, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 03, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
December 03, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
December 03, 2021
From Benzinga
SWBI Stock: Why Smith & Wesson Shares Are Getting Gunned Down Today
December 03, 2021
From InvestorPlace
Hot Biotech Stocks: Why Celyad Oncology (CYAD) Is Soaring Higher Today
December 03, 2021
From InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
December 03, 2021
From Benzinga
Celyad Oncology Shares Gain After Fortress Injects $32M Via Equity
December 03, 2021
Tickers
CYAD
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 03, 2021
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga